Radioactive iodine thyroid uptake in patients with amiodarone-iodine-induced thyroid dysfunction

Area of Science:

• Endocrinology
• Pharmacology
• Nuclear Medicine

Background:

• Amiodarone is a widely used antiarrhythmic drug, notable for its high iodine content.
• This iodine load makes amiodarone a significant cause of thyroid dysfunction, including both hypothyroidism and thyrotoxicosis.
• Understanding the mechanisms behind amiodarone-induced thyroid dysfunction is crucial for patient management.

Purpose of the Study:

• To investigate the diagnostic utility of radioiodine ({0}) uptake and the perchlorate discharge test in differentiating amiodarone-induced hypothyroidism and thyrotoxicosis.
• To analyze {0} uptake patterns in relation to underlying thyroid status in patients treated with amiodarone.

Main Methods:

• Assessment of {0} thyroid uptake in patients with amiodarone-induced thyroid dysfunction.
• Performance of the perchlorate discharge test in a cohort of patients with amiodarone-induced hypothyroidism and thyrotoxicosis.
• Correlation of {0} uptake and perchlorate discharge test results with clinical presentation and underlying thyroid conditions.

Main Results:

• {0} thyroid uptake was detectable in patients with amiodarone-induced hypothyroidism, regardless of pre-existing thyroid disease.
• {0} uptake was normal or elevated in amiodarone-induced thyrotoxicosis patients with underlying thyroid disorders, but very low in those with a normal thyroid gland.
• The perchlorate discharge test was positive in all 8 hypothyroid patients and negative in all 5 hyperthyroid patients studied.

Conclusions:

• Radioiodine ({0}) uptake patterns and perchlorate discharge test results offer valuable insights into the pathophysiology of amiodarone-induced thyroid dysfunction.
• These diagnostic tools can aid in distinguishing between amiodarone-induced hypothyroidism and thyrotoxicosis, informing clinical decision-making.